Reference
Abbey R, et al. Cost-Benefit Analysis of Indirect Antiglobulin Screening in Rh(D)-Negative Women at 28 Weeks of Gestation. Obstetrics and Gynecology 123: 938-945, No. 5, May 2014. Available from: URL: http://doi.org/10.1097/AOG.0000000000000224
Rights and permissions
About this article
Cite this article
Two screenings unnecessary for most Rh(D)-negative US women. PharmacoEcon Outcomes News 703, 7 (2014). https://doi.org/10.1007/s40274-014-1262-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1262-8